RxDoctor Payments Data

Sakeba Issa

Rheumatology · Joliet, ILNPI 1164475505

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.6% of the total across 176 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Amgen at 27.4% of the total. Reporting peaked in 2019 at $2,307 and has fallen 99.0% since, to $22 in 2021.

$3,162in general payments, 2019–2025

Across 176 payments — averaging $17.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$866
  • AbbVie$398
  • Pfizer$348
  • Novartis$285
  • Johnson & Johnson$214
  • Lilly USA, LLC$192
  • plus $860 from 15 others
$500in research payments, 2019–2025

Across 1 payment — averaging $500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • UCB Biosciences Inc.$500

What the payments were for

  • Food & beverage$3,08798%
  • Education$752%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,162 in reported general payments places this provider in the 65th percentile of 287 rheumatology providers in Illinois.

See all rheumatology providers in Illinois →

Other rheumatology in Joliet

See the full list for Illinois →

Where these figures come from

Is this you, or does something look wrong? →